Pancontinental Energy NL (PCOGF)

CTI BioPharma Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	3.6	4.3	5.3	0.27	0.39	0.57
Cash & Short-Term Investments	3.6	4.3	5.3	0.27	0.39	0.57
Cash Growth	-20.96%	-18.86%	1834.28%	-30.52%	-30.48%	-71.83%
Accounts Receivable	0.1	0.1	0.07	0.07	0.07	0.13
Receivables	0.1	0.1	0.07	0.07	0.07	0.13
Total Current Assets	3.7	4.4	5.37	0.34	0.46	0.69
Property, Plant & Equipment	5.06	4.7	4.07	3.31	3	2.83
Total Assets	8.76	9.1	9.45	3.65	3.47	3.52
Accounts Payable	0.18	0.15	0.15	0.2	0.17	0.11
Accrued Expenses	0.22	0.19	0.1	-	-	-
Other Current Liabilities	0.48	0.48	-	-	-	-
Total Current Liabilities	0.88	0.81	0.25	0.2	0.17	0.11
Long-Term Debt	-	-	0.48	0.48	0.48	0.48
Other Long-Term Liabilities	0.01	0.01	0.05	-	0.11	-
Total Liabilities	0.9	0.82	0.78	0.71	0.79	0.61
Common Stock	9.33	9.75	10.14	4.45	4.19	4.41
Total Common Equity	9.33	9.75	10.14	4.45	4.19	4.41
Minority Interest	-1.47	-1.47	-1.47	-1.51	-1.51	-1.51
Shareholders' Equity	7.86	8.28	8.67	2.94	2.68	2.91
Total Liabilities & Equity	8.76	9.1	9.45	3.65	3.47	3.52
Total Debt	-	-	0.48	0.48	0.48	0.48
Net Cash (Debt)	3.6	4.3	4.82	-0.2	-0.08	0.09
Net Cash Growth	-11.73%	-10.85%	-	-	-	-93.23%
Net Cash Per Share	0.00	0.00	0.00	-0.00	-0.00	0.00
Filing Date Shares Outstanding	8,132	8,132	8,054	7,154	6,007	5,407
Total Common Shares Outstanding	8,132	8,132	8,054	7,154	6,007	5,407
Working Capital	2.82	3.59	5.12	0.15	0.29	0.58
Book Value Per Share	0.00	0.00	0.00	0.00	0.00	0.00
Tangible Book Value	9.33	9.75	10.14	4.45	4.19	4.41
Tangible Book Value Per Share	0.00	0.00	0.00	0.00	0.00	0.00
Machinery	-	0.03	0.03	0.03	0.03	0.11

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.